Tag Archives: OLLI

Top 5 Blue Chip Stocks To Own Right Now

Shutterstock

Today I’m going to show you 2 easy ways to set yourself up for safe double-digit yearly dividend growth and invite quick 100%+ upside too.

I’ll also reveal a blue chip stock that’s delivering both strong price gains and rising dividends. It will have you pocketing a nice 5%+ yield in short order.

So let’s get going, starting with…

The Dividend-Growth Signal Most People Miss

If you’ve been buying dividend stocks for a while, you probably know about the payout ratio.

It’s a sacred cow for many folks; you calculate it by dividing the total amount of dividends paid by the company’s last 12 months of net income.

If it comes out in the neighborhood of, say, 50% or less, you’ve got a safe dividend that’s likely to grow. As you get climb closer to 100%, the noose around the payout gets tighter.

Top 5 Blue Chip Stocks To Own Right Now: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, financial shares slipped by 0.55 percent. Meanwhile, top losers in the sector included Greenhill & Co., Inc. (NYSE: GHL), down 11 percent, and SVB Financial Group (NASDAQ: SIVB), down 8 percent.

  • [By Jim Robertson]

    For investors with a long memory, the Iridium communications service was launched on November 1, 1998 only for the founding company to go into Chapter 11 bankruptcy nine months later as the cost of service was prohibitive for many users. Iridium Satellite LLC was eventually merged with a special purpose acquisition company (GHQ) created by the investment bank Greenhill & Co. (NYSE: GHL) in September 2009 to form Iridium Communications.

Top 5 Blue Chip Stocks To Own Right Now: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Lisa Levin]

    In trading on Friday, non-cyclical consumer goods & services shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Medifast Inc (NYSE: MED), down 5 percent, and Bridgford Foods Corporation (NASDAQ: BRID), down 6 percent.

  • [By Peter Graham]

    A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) still underperforming whileNutriSystem Inc (NASDAQ: NTRI) and Medifast Inc (NYSE: MED) began taking off early last year:

  • [By Peter Graham]

    Although obesity is widespread, small cap dieting stocks havetended to causeinvestor portfolios to loose weight. A long term performance chart shows small cap weight loss or dieting stocks Weight Watchers International and Reliv International, Inc (NASDAQ: RELV) stillbelow or at breakeven for longer term investors whileMedifast Inc (NYSE: MED)has performed better and NutriSystem Inc (NASDAQ: NTRI) hasfinally begun to take offearly last year:

Top 5 Blue Chip Stocks To Own Right Now: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

  • [By Monica Gerson]

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

Top 5 Blue Chip Stocks To Own Right Now: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Who is at the lower-end of the range for 2016 payout ratios? We expect Zions Bancorporation, Huntington Bancshares (HBAN), andBank of America to seek the least amount of capital return in 2016 (ranging between 50-60% of estimated earnings).

Top 5 Blue Chip Stocks To Own Right Now: Mitsubishi Corporation (MSBHY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Mitsubishi (OTCPK:MSBHY)

    Earlier in 2016, Mitsubishi released its 2017 i-MiEV. It is fully electric, with a 16 kWh lithium-ion battery pack and a range of 62 miles. Basically just a short trips car, as the range is really very low. Mitsubishi also has its popular plug in hybrid Outlander model that sells quite well. As stated last month, the company announced “plans to launch a compact EV with 250-mile range by 2020”. Mitsubishi is currently ranked 7th in global EV sales.

  • [By SEEKINGALPHA.COM]

    Renault Nissan (OTC:RNSDF) (NSANY)/Mitsubishi (OTCPK:MSBHY) (MMTOF)

    On December 20, Green Car Reports reported: “Mitsubishi electric cars to use Nissan-Renault platforms.” Remember Mitsubishi has the US$22,995 all-electric 16 kWh iMiEV coming out in 2017.

TJX Companies Inc Stock Is Cheap and for Good Reason

There are two potential concerns when it comes to TJX Companies Inc (NYSE:TJX). The first is the health of the overall off-price space. As with all areas of retail, Amazon.com, Inc. (NASDAQ:AMZN) and other e-commerce providers create a potential competitive threat. The second is TJX’s competitiveness within that space.

TJX Companies Inc Stock Is Cheap and for Good Reasoninvestorplace.com/wp-content/uploads/2016/07/tjxmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/07/tjxmsn-170×93.jpg 170w, investorplace.com/wp-content/uploads/2016/07/tjxmsn.jpg 728w” sizes=”(max-width:300px) 100vw, 300px” /> Source: Mike Mozart via Flickr

So far, the first risk hasn’t really played out. TJX news in terms of traffic has been pretty solid, with the figure rising 2% even in what looked like a disappointing Q3 report last week.

Rival Ross Stores, Inc. (NASDAQ:ROST) saw its customer count rise as well, meaning the defection to online shopping seen in other areas of retail hasn’t played out — yet.

The second risk might not get the same coverage, particularly given TJX’s reputation. But it’s a concern nonetheless. TJX stock has underperformed its space badly of late. Since Ollie’s Bargain Outlet Holdings Inc (NASDAQ:OLLI) went public in July 2015, OLLI stock has gained 118%. Burlington Stores Inc (NYSE:BURL) has doubled, and ROST has risen 43%.

In contrast, TJX stock has gained less than 8% in those 26 months. Of course, there are two ways to view that underperformance. It does leave TJX stock relatively cheap and perhaps “due” to catch up with the rest of the space.

But, from here, the weakness of late even in a strong sector is a major concern. If this is how the company performs with its sector healthy and the economy strong, what happens if and when the external environment gets worse?

The Amazon Threat to TJX

It’s worth pointing out that the concern about e-commerce competition for brick-and-mortar retailers like TJX isn’t just a concern about Amazon, or other players, taking all of their revenue.

What’s been seen at mall retailers, for instance, generally is a 10-20% reduction in revenue. But given the fixed expense of rent and the increasing cost of labor, that seemingly modest pressure is enough to decimate profits. Even flat sales, for a retailer, eventually will cause profits to decline as expenses rise and margins erode.

So far, the off-price channel has held up just fine. TJX same-store sales rose a strong 5% in FY17 (ending January) and have gained 1%+ through the first nine months of FY18, even with what the company admitted was a series of merchandise misses in Q3. Other names in the industry continue to grow sales and profits as well.

The question is whether that will change. And I still believe it might, even if a shift to e-commerce so far hasn’t had the same devastating impact seen at department stores and mall retailers. So far, no one really has replicated the off-price model online (not even TJX or Ross, both of whom drive a minimal percentage of revenue through their respective websites). And it’s possible no one will.

But it’s also possible that direct online competition will arise. The obvious, and concerning, potential parallel here is in the auto parts space. A year ago, that sector looked something close to Amazon-proof. Since then, Advance Auto Parts, Inc. (NYSE:AAP) has fallen 44%, and rivals O’Reilly Automotive Inc (NASDAQ:ORLY) and AutoZone, Inc. (NYSE:AZO) have fallen 16-17%.

Next Page

Again, the Amazon effect isn’t binary; it’s not a matter of all, or even most, sales moving online. A point here and a point there starts to make a big dent on profit, as retail stocks have shown over the past few years. That’s a potential risk to TJX stock going forward.

The Off-Price Market

To some extent, that risk does seem priced into TJX stock. It still trades for about 18x FY19 analyst estimates, despite guidance suggesting ~8% growth this year (excluding the impact of an extra week) and 6% growth a year ago.

But the broader concern is that TJX is lagging both rival Ross and its younger, smaller peers. Ross has grown comps 4% in each of the last two years, and is guiding toward a similar number this year. EPS is guided to rise roughly 15%.

Burlington grew adjusted net income 33% last year and expects a 28% increase this year. Ollie’s posted 50% non-GAAP earnings growth last year and 32% in the first half of this fiscal year.

Those stocks are more expensive than TJX on an earnings basis, but investors so far have gotten what they’ve paid for. As noted, the company has underperformed.

The key question is: will that change? And, if so, how? TJX’s HomeGoods concept is performing well but generates roughly 10% of revenue. The core “Marmaxx” (Marshalls and T.J. Maxx) banners are losing share. Margins are compressing, albeit modestly.

The trajectory of the business really isn’t that great at the moment. That means there’s a bit of a turnaround already priced into TJX stock, even though news really hasn’t been that impressive of late.

Q3 results showed that issue, with ROST outperforming TJX both in terms of fundamentals and stock price gains. And that gap has to narrow, at least, for the company to see upside. On this site, Nicholas Chahine made a good argument for buying the post-earnings dip in TJX stock. But there’s more to consider here than just the price.

Simply put, TJX isn’t performing as well as it should be, or as well as its reputation suggests. That’s a bigger risk than the one posed by e-commerce, and it’s one I’m not yet interested in taking.

As of this writing, Vince Martin has no positions in any securities mentioned.

penny stock finder

Which biotechs have high prospects of being acquired in the near future? Many would place Incyte (NASDAQ:INCY) near the top of the list. The company’s oncology portfolio makes it an attractive target.But a target for whom?

Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), and Amgen (NASDAQ:AMGN) stand out as three of the most likely suitors for Incyte. Here’s why these big drugmakers could be interested in making a significant acquisition.

Image source: Getty Images.

A perfect match

When industry observers were asked in 2016 which company they thought was most likely to buy Incyte, Gilead Sciences was the top answer. In some ways, Gilead and Incyte make an ideal match.

Investors are anxious for Gilead to make an acquisition to help plug the leak from its declining hepatitis C franchise sales. Gilead’s executives have also stated that a strategic deal ranks as one of their top priorities. The company’s CEO even identified strengthening Gilead’s oncology product lineup as a primary objective, but also mentioned augmenting its inflammation and non-alcoholic steatohepatitis (NASH) pipelines.

penny stock finder: Arena Pharmaceuticals, Inc.(ARNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.09 percent. Meanwhile, top losers in the sector included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), down 6 percent, and Omeros Corporation (NASDAQ: OMER), down 5 percent.

  • [By Paul Ausick]

    Arena Pharmaceuticals Inc. (NASDAQ: ARNA) posted a new 52-week low of $1.20 on Tuesday, down about 19% compared with Monday’s closing price of $1.48. The stock’s 52-week high is $2.16. Volume was about 10% below the daily average of around 3.8 million shares. The company priced a secondary offering of 60 million shares at $1.15 per share, a path guaranteed to enrage existing investors.

  • [By Keith Speights]

    Eisai partnered with Arena Pharmaceuticals (NASDAQ:ARNA) several years ago on obesity drug Belviq. The drug won U.S. regulatory approval in 2012, but sales have been underwhelming. As a result, Arena sold Belviq to Eisai earlier this year.

penny stock finder: Washington Trust Bancorp, Inc.(WASH)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

penny stock finder: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

  • [By Monica Gerson]

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

penny stock finder: TransAlta Corporation(TAC)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, utilities shares fell by 0.08 percent. Meanwhile, top losers in the sector included FirstEnergy Corp. (NYSE: FE), down 3 percent, and TransAlta Corporation (USA) (NYSE: TAC), down 2 percent.

  • [By Lisa Levin]

    In trading on Friday, utilities shares rose by just 0.5 percent. Meanwhile, top losers in the sector included TransAlta Corporation (USA) (NYSE: TAC), down 1 percent, and Huaneng Power International Inc (ADR) (NYSE: HNP), down 1 percent.

  • [By Lisa Levin]

    In trading on Monday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Companhia Paranaense de Energia (ADR) (NYSE: ELP), down 3.5 percent, and TransAlta Corporation (USA) (NYSE: TAC), down 5 percent.

penny stock finder: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Masco (MAS) , American Electric Power (AEP) and Valmont Industries (VMI) .

    Cramer was bearish on Wisconsin Energy (WEC) .

penny stock finder: EQT GP Holdings, LP(EQGP)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Not only does Jana consider the deal price overvalued, but it looks to redirect EQT’s focus to a breakup of pipeline operations to transform the core company into an exploration & production firm. The pipelines already trade publicly under EQT Midstream Partners LP (NYSE: EQM) and EQT GP Holdings LP (NYSE: EQGP).

learn about stock market

DryShips Inc (NASDAQ:DRYS) filed a 6-K this morning announcing the restructuring of its SIFNOS revolver. Here are the pertinent points.

The revolver will no longer be secured by all present and future vessels owned by DRYS. The spread over LIBOR increases 100 bp to 650. The maturity date is extended five years. $2 million restructuring fee is paid to SIFNOS. 30% profit share on vessels sold remains in place.

Implications

The extension of the maturity of the SIFNOS debt and the release of all security are critical elements in securing outside debt financing. No entity was going to lend money to DRYS as long as the $200 million SIFNOS loan was due in less than 3 years. The release of all security for all present and future vessels allows any lender to be well over-collateralized on any loan made with DRYS. This is a key element given GE’s (NYSE:GE) poor reputation.

This announcement does not guarantee a successful origination of debt but it does clear the path. If DRYS is able to raise debt capital at a reasonable cost, it would relieve to the need to complete some or all of the remaining $188 million of equity capital under its most recent Prospectus Supplement and could potentially have a dramatic impact on the stock price. Analyses of the current equity offering can be found amongst these articles.

learn about stock market: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls
    Baird downgraded Cardinal Health (NYSE: CAH) to Neutral.
    Imperial downgraded Brinks (NYSE: BCO) to In-Line.
    Jefferies upgraded AK Steel (NYSE: AKS) to Buy.
    Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy.
    Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

learn about stock market: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

learn about stock market: Crestwood Equity Partners LP(CEQP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Crestwood Equity Partners LP (NYSE: CEQP) shares shot up 45 percent to $18.54 following the announcement of a new joint venture with Consolidated Edison, Inc. (NYSE: ED). Subsidiaries of both companies entered into an agreement on Thursday to form a joint venture in which they will jointly own and develop Crestwood’s existing natural gas pipeline and storage business in norther Pennsylvania and southern New York.

learn about stock market: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

learn about stock market: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    If Under Armour (UAA) , (UA) shareholders didn’t have bad luck, they wouldn’t have any luck at all. UAA shares are down around 30% year to date and more than 50% in the last 12 months. I thought these guys were supposed to be the next Nike (NKE) .

  • [By Nelson Hem]

    Wayne Duggan’s “Usual Suspects Among Hottest Stocks To Short” offers a look at some of last week’s most popular stocks with short sellers. See why Snap Inc (NYSE: SNAP) and Under Armour Inc (NYSE: UAA) made the list, as well as a struggling retailer, a recent IPO and several others.

  • [By Seth McNew]

    Nike(NYSE:NKE), Under Armour (NYSE:UAA)(NYSE:UA), and other clothing brands have been talking a lot lately about the need to overhaul their manufacturing processes as a way to reduce costs, improve quality, and have more flexibility. The textile manufacturing process has changed relatively slowly compared with other industries, but that could change soon as more and more focus is put on disrupting it.

  • [By Ben Levisohn]

    Yesterday, Under Armour (UAA) reported disappointing earnings and cut its revenue-growth forecast in half. That prompted seven analysts to cut its stock yesterday, including those at Susquehanna, Piper Jaffray, Raymond James, BofA Merrill Lynch, Wells Fargo, B. Riley, and Credit Suisse. And the downgrades have continued today, with analysts at Evercore ISI, FBR, and Canaccord Genuity joining the downgrade party.

    Getty Images

    Isn’t it a little late, now that the stock has lost a quarter of its value? Canaccord’s Camilo Lyon and Pallav Saini don’t think so:

    Following surprisingly weak Q4 results and further reduction in 2017 guidance, we are downgradingUnder Armour stock to HOLD from Buy. While EPS of 23c came in slightly below our 25c consensus estimate, sales (+12%) and gross margin (-314bps) were significantly below guidance and our expectations. The disappointing results were largely driven by weak NA apparel business, which continues to be plagued by sporting goods bankruptcies, limited lifestyle/fashion merchandise in Under Armour’s assortment, and heavy promotional activity by Nike (NKE) and Adidas to whichUnder Armour responded late. WhileUnder Armour is taking steps to rectify the assortment missteps in apparel by increasing its lifestyle offering, we are not likely to see a significant improvement before 2018. That said, there were pockets of growth within apparel, mainly golf and basketball, that underscore the value of the brand. While growth continues to be robust in footwear (+36%), international (+55%) and DTC (+23%), we believe the challenges in Under Armour’s NA apparel business will continue to weigh on the business in 2017. In addition, recent news reports suggest there are more sporting goods retailers (e.g. EMS, Gander Mountain, Bob’s Sports) on the verge of bankruptcy, which could put further downward pressure on athletic vendors. Lastly,Under Armour continues to invest aggressivel

  • [By Leo Sun]

    Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

learn about stock market: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By Monica Gerson] Related CSC Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Computer Sciences' (CSC) CEO Mike Lawrie on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise … (GuruFocus)

    Some of the stocks that may grab investor focus today are:

  • [By R. Chandrasekaran]

    Some of the outperforming stocks:

    NVDIA Corp (NASDAQ: NVDA) trading up about 5.7 percent with a range between $69.50 and $71.72.
    Amazon.com, Inc. (NASDAQ: AMZN) is gaining about 4 percent. The stock ranged between $770.94 and $787.73.
    Computer Sciences Corporation (NYSE: CSC) is gaining about 3.3 percent with the stock trading between $56.10 and $58.01.
    Microsoft Corporation (NASDAQ: MSFT) is adding about 3 percent with the stock ranging $59.78-$60.52.
    Alphabet Inc (NASDAQ: GOOGL) is gaining about 2.9 percent with the stock trading between $792.90 and $805.
    Intel Corporation (NASDAQ: INTC) is adding approximately 2.9 percent with shares trading in the range of $34.15-$34.60.
    Cisco Systems, Inc. (NASDAQ: CSCO) is gaining about 2.8 percent as the stock traded between $30.61 and $31.05.
    Salesforce.com, inc. (NYSE: CRM) is adding about 2.8 percent with the shares traded in the range of $75.41-$77.00

Top Warren Buffett Stocks To Buy Right Now

Warren Buffett’s Berkshire Hathaway Energy – a portfolio worth $85 billion that includes renewable energy companies – just made a huge bet on “Big Data.”

In March, BHE announced that two of its subsidiary companies (though not parent company BHE itself) would partner with the young Chicago-based software startup Uptake Technologies to track their wind turbines.

In fact, the startup is so new that Buffett’s Berkshire Hathaway is Uptake’s very first publicly announced customer.

So what does Buffett see in this little-known “unicorn” startup? And more importantly, how could you profit from the same technology? Let’s take a look…

Top Warren Buffett Stocks To Buy Right Now: Medidata Solutions, Inc.(MDSO)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

  • [By Peter Graham]

    A long term performance chart shows shares of Veeva Systems outperformingunderperforming small cap peerModel N Inc (NYSE: MODN) while mid cap Medidata Solutions (NASDAQ: MDSO) has been a huge outperformer that has just moved past its 2014 peak:

Top Warren Buffett Stocks To Buy Right Now: Ollie's Bargain Outlet Holdings, Inc.(OLLI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) is estimated to post its quarterly earnings at $0.17 per share on revenue of $190.44 million.

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

Top Warren Buffett Stocks To Buy Right Now: Ethan Allen Interiors Inc.(ETH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump weighed on the healthcare sector, and some individual stocks took particularly hard hits. Among the worst performers were Perrigo (NYSE:PRGO), Novadaq Technologies (NASDAQ:NVDQ), and Ethan Allen Interiors (NYSE:ETH). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top Warren Buffett Stocks To Buy Right Now: National Grid Transco, PLC(NGG)

Advisors’ Opinion:

  • [By Travis Hoium]

    National Grid (NYSE:NGG) came out with some interesting information last week, saying 2.4 GW of distributed solar was added in the U.K. between February 2016 and February 2017 and another 1.5 GW is expected in the next year. The U.K. isn’t exactly a hotbed for solar activity, but it’s growing as an important market.

  • [By Lisa Levin]

    Tuesday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from National Grid plc (ADR) (NYSE: NGG) and Dominion Resources, Inc. (NYSE: D).

  • [By WWW.MONEYSHOW.COM]

    Among utilities, National Grid (NGG) is my best pick for 2017, as it’s an almost perfect hedge against uncertainty. It’s insulated from changes in government interest rates. It can be both an inflation hedge and a play on a strong dollar.

  • [By Tyler Crowe, Dan Caplinger, and Neha Chamaria]

    We asked three of our contributors to highlight a stock they see as a dividend stock to buy in February. They responded with automaker Ford Motors (NYSE:F), oil and gas logistics company Enterprise Products Partners (NYSE:EPD), and electricity transmission specialist National Grid (NYSE:NGG). Here’s a quick run-down as to why investors should take a look at these high-yield stocks.

Top Warren Buffett Stocks To Buy Right Now: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. AlthoughValeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion forValeant shares (on P/E).

  • [By Lisa Levin]

    Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.